Abstract: A flexible display device and a method and apparatus for controlling the same. An apparatus for controlling a display device includes the display device formed of a foldable material and folded along at least two parallel virtual folding lines, and a control unit for controlling a display of the display device based on a folded position and a folding direction of the display device, wherein the display device is configured to be foldable in a first direction at a first folding line, and is configured to be foldable in a second direction that is opposite to the first direction at a second folding line adjacent to the first folding line, wherein the first folding line is any one of the at least two parallel virtual folding lines, and the second folding line is a remaining one of the at least two parallel virtual folding lines.

Abstract: A backlight unit is provided. The backlight unit includes: a mold frame having a predetermined receiving space formed therein; a light guide plate disposed in the receiving space of the mold frame, and having an inclined surface formed on one side of the top surface so as to be inclined toward the inner side; a light source disposed between the light guide plate and the mold frame to emit light to the light guide plate; and a flexible printed circuit board, on which the light source is mounted, and which is supported in contact with the top surface of the light guide plate, wherein a stepped portion is formed on one end of the light guide plate, including a flat adhesion surface positioned at a height lower than one end face of the light guide plate.

Abstract: A display device includes a display panel having an upper surface and being configured to display an image, a mold frame configured to receive the display panel, and a lower receiving member having an inner wall disposed on a peripheral area thereof and being configured to receive mold frame and the display panel. The mold frame includes a peripheral area disposed around an open portion of the mold frame, and a side wall disposed in the peripheral area. The side wall of the mold frame is connected to the inner wall of the lower receiving member, and the panel supporter of the mold frame is disposed on the upper surface of the display panel to support the display panel.

Abstract: A light guiding plate to enhance uniformity of brightness and a backlight assembly and a display device having the same in one or more embodiments. In one embodiment, the light guiding plate includes a plurality of the linear shaped prisms on a back surface thereof, and the linear shaped prisms are omitted partially at the incident portion of the light guiding plate such that a non-prism area, connection area, and prism area are formed in stated order from the incident portion end on the back surface of the light guiding plate. Therefore, the display device having the light guiding plate is adapted to increase a uniformity of brightness of the edge type backlight, and the display quality can be improved.

Abstract: An LCD device includes a substrate including a gate line, a data line, and a thin film transistor at a crossing region of the gate line and the data line, wherein the gate line and the data line define a pixel region, the LCD device also includes a pixel electrode, a common electrode separated from the pixel electrode, wherein the pixel electrode and the common electrode are alternately arranged in the pixel region, and an alignment layer on the pixel electrode and the common electrode, between the pixel electrode and the common electrode, and in a region adjacent to the pixel electrode, wherein the alignment layer has an upper surface having a substantially uniform height.

Abstract: An apparatus for etching a glass substrate includes a vessel configured to contain an etchant; a first plate in the vessel and configured to receive a horizontally placed glass substrate thereon; and a circulating unit in the vessel facing the first plate and configured to create a flow of the etchant on a side of the first plate.

Abstract: An organic light-emitting apparatus and a method of manufacturing the same are provided.

Abstract: A backlight unit is provided. The backlight unit includes: a mold frame having a predetermined receiving space formed therein; a light guide plate disposed in the receiving space of the mold frame, and having an inclined surface formed on one side of the top surface so as to be inclined toward the inner side; a light source disposed between the light guide plate and the mold frame to emit light to the light guide plate; and a flexible printed circuit board, on which the light source is mounted, and which is supported in contact with the top surface of the light guide plate, wherein a stepped portion is formed on one end of the light guide plate, including a flat adhesion surface positioned at a height lower than one end face of the light guide plate.

Abstract: The present invention provides a pharmaceutical formulation comprising an immediate-release compartment containing an angiotensin-2 receptor blocker (ARB) as a pharmacologically active ingredient and an extended-release compartment containing a non-dihydropyridine calcium channel blocker as a pharmacologically active ingredient. Since the disclosed formulation enables the release of the two ingredients at a different time, it reduces side effects and increases the effects of the drug more than the case of separately administering the ingredients each at the same time. In addition, the formulation maximizes the effects of drug at the time of day when the complication risk of cardiovascular system diseases is highest.

Abstract: The present invention provides a pharmaceutical formulation containing an angiotensin-II receptor blocker and a release-control material as a pharmacologically active ingredient and a pharmaceutical formulation comprising an immediate-release compartment and an extended-release compartment. The immediate-release compartment contains an agent as a pharmacologically active ingredient for preventing and inhibiting hepatitis and the extended-release compartment has an angiotensin-II receptor blocker as a pharmacologically active ingredient. The formulation of the present invention maximizes the effectiveness on pharmacologically and clinically lowering blood pressure and preventing complications when taking the formulation, helps to avoid interaction with a drug which is metabolized by the same enzyme in the liver, and prevents and inhibits the incidence of drug-induced hepatitis which is caused by drug administration for a long time.

Abstract: A light guiding plate to enhance uniformity of brightness and a backlight assembly and a display device having the same in one or more embodiments. In one embodiment, the light guiding plate includes a plurality of the linear shaped prisms on a back surface thereof, and the linear shaped prisms are omitted partially at the incident portion of the light guiding plate such that a non-prism area, connection area, and prism area are formed in stated order from the incident portion end on the back surface of the light guiding plate. Therefore, the display device having the light guiding plate is adapted to increase a uniformity of brightness of the edge type backlight, and the display quality can be improved.

Abstract: A display device includes a display panel having an upper surface and being configured to display an image, a mold frame configured to receive the display panel, and a lower receiving member having an inner wall disposed on a peripheral area thereof and being configured to receive mold frame and the display panel. The mold frame includes a peripheral area disposed around an open portion of the mold frame, and a side wall disposed in the peripheral area. The side wall of the mold frame is connected to the inner wall of the lower receiving member, and the panel supporter of the mold frame is disposed on the upper surface of the display panel to support the display panel.

Abstract: The present invention relates to a simple and effective method for preparing a tamsulosin HCl sustained-release tablet and a tamsulosin HCl sustained-release tablet produced thereby. The method comprises the steps of: dissolving tamsulosin HCl as an active ingredient in an organic solvent; dissolving the tamsulosin HCl solution in hydroxypropylmethylcellulose phthalate to prepare a binder solution; and kneading the binder solution with a hydroxypropylmethylcellulose phthalate/glyceryl dibehenate mixture as an excipient and allows tamsulosin HCl to be released at uniformly controlled amounts in a subtained-release manner in vivo by controlling drug release rate according to different pH environments in vivo, so that it shows improved bioavailability and minimized side effects.

Abstract: The present invention relates to a simple and effective method for preparing a tamsulosin HCl sustained-release tablet and a tamsulosin HCl sustained-release tablet produced thereby. The method comprises the steps of: dissolving tamsulosin HCl as an active ingredient in an organic solvent; dissolving the tamsulosin HCl solution in hydroxypropylmethylcellulose phthalate to prepare a binder solution; and kneading the binder solution with a hydroxypropylmethylcellulose phthalate/glyceryl dibehenate mixture as an excipient and allows tamsulosin HCl to be released at uniformly controlled amounts in a subtained-release manner in vivo by controlling drug release rate according to different pH environments in vivo, so that it shows improved bioavailability and minimized side effects.